Skip to main content
. 2020 Sep 25;10(10):451. doi: 10.1007/s13205-020-02438-4

Fig. 5.

Fig. 5

Intracellular granulysin expression analysis in human PBMC after 48 and 72 h of treatment with D. oil at 10 μg/ml. Untreated PBMC (control) and Con A treated PBMC were taken as negative and positive controls, respectively. Treated PBMC were fixed, permeabilized and probed with anti-granulysin antibody. Followed by treatment with secondary antibody (anti-rabbit IgG Allophycocyanin) and flow cytometry analysis. Results were expressed as percentage of granulysin positive cells